KalVista Pharmaceuticals, Inc.
KALV · NASDAQ
9/30/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,482 | -$60,096 | -$52,226 | -$48,508 |
| Dep. & Amort. | $229 | $252 | $275 | $229 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,193 | $0 | -$8,649 | $2,610 |
| Change in WC | $4,814 | -$4,699 | $18,785 | $5,593 |
| Other Non-Cash | $5,565 | $10,041 | $1,451 | $7,395 |
| Operating Cash Flow | -$32,681 | -$54,502 | -$40,364 | -$32,681 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$24 | -$290 | $24 | -$24 |
| Net Acquisitions | $0 | $0 | $434 | $0 |
| Inv. Purchases | $0 | -$19,979 | $38,118 | -$6,563 |
| Inv. Sales/Matur. | $0 | $41,677 | $21,177 | $15,207 |
| Other Inv. Act. | $8,541 | -$147 | -$63,081 | -$103 |
| Investing Cash Flow | $8,517 | $21,261 | -$3,328 | $8,517 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $21,921 | $2,810 | $0 |
| Stock Issued | $0 | $1,289 | $1,849 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $151,773 | $0 | $0 | $151,773 |
| Financing Cash Flow | $151,773 | $23,210 | $4,659 | $151,773 |
| Forex Effect | -$1,249 | $2,720 | $3,364 | -$1,249 |
| Net Chg. in Cash | $126,360 | -$7,311 | -$35,669 | $126,360 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,581 | $131,615 | $167,941 | $41,581 |
| End Cash | $167,941 | $124,304 | $132,272 | $167,941 |
| Free Cash Flow | -$32,705 | -$54,792 | -$40,014 | -$32,808 |